Disease | collagen disease |
Symptom | C0029456|osteoporosis |
Sentences | 2 |
PubMedID- 24324644 | Rcts of large sample size trials with long-term follow-up are needed to further determine the efficacy and optimal usage of bps in managing osteoporosis in patients with rheumatic diseases. |
PubMedID- 20406615 | Objectives: in the 18 month "alendronate or alfacalcidol in glucocorticoid-induced osteoporosis"-trial (stop-trial) patients with rheumatic diseases who started glucocorticoids were randomised to anti-osteoporosis therapy with either daily alendronate (10 mg) or alfacalcidol (1 microg). |
Page: 1